Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification
- 1 November 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 10 (11), 1590-1600
- https://doi.org/10.1097/jto.0000000000000685
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancersScientific Reports, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2012
- Suppression of lung adenocarcinoma progression by Nkx2-1Nature, 2011
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNature Genetics, 2009
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsAnnals of Oncology, 2009
- Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerOncogene, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancerProceedings of the National Academy of Sciences of the United States of America, 2007